Home Clinical Trials Browse by State Browse by City Hepatitis B Guides About Contact

🧪 Paid Hepatitis B Clinical Trials

Browse recruiting hepatitis b clinical trials across the United States. Find eligibility information, locations and research opportunities near you.

Loading...
Active Studies
Hepatitis B
Condition

Active Clinical Trials for Hepatitis B

Showing live studies from ClinicalTrials.gov. Data refreshes daily.

Loading studies...

Disclaimer: This content is for educational purposes and is not medical advice. Always consult a qualified healthcare provider for medical guidance.

About Hepatitis B

Hepatitis B is a viral infection causing liver inflammation that can become chronic and lead to cirrhosis or liver cancer. Clinical trials investigate new antiviral therapies, immune-based treatments, and functional cure strategies.

Common Symptoms

Fatigue, jaundice, abdominal pain, nausea, vomiting, dark urine, joint pain, loss of appetite, fever

Risk Factors

Birth to infected mother, unprotected sex, sharing needles, occupational exposure, hemodialysis, travel to endemic areas

Treatment Overview

Treatment includes antiviral medications (tenofovir, entecavir) and pegylated interferon. Clinical trials explore novel entry inhibitors, capsid inhibitors, RNA interference therapies, and immunomodulatory approaches toward functional cure.

Why Participate?

Hepatitis B clinical trials are essential for developing finite treatment regimens and potential cures for the hundreds of millions living with chronic hepatitis B worldwide.

Related Conditions

States with Hepatitis B Clinical Trials

Cities with Hepatitis B Clinical Trials

Frequently Asked Questions About Hepatitis B Clinical Trials

Hepatitis B clinical trials test new antiviral medications and immune-based therapies to improve viral suppression and potentially achieve functional cure.
Eligibility depends on hepatitis B status (chronic vs. resolved), viral load, liver function, and prior treatment history.
Compensation varies. Participants typically receive $50-$200 per visit with study medications and monitoring provided at no cost.
Yes, participants receive regular liver function monitoring and viral load testing. All trials follow strict safety protocols.